Advertisement

Inpharma Weekly

, Volume 1624, Issue 1, pp 21–21 | Cite as

Sorafenib approved for liver cancer in Canada

Media release
  • 5 Downloads

Keywords

Carcinoma Cancer Patient Hepatocellular Carcinoma Drug Therapy Sorafenib 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2008

Personalised recommendations